Federal Register / Vol. 61, No. 91 / Thursday, May 9, 1996 / Notices 21185

follows: SW Taylor Street on the north,

SW 1st Avenue on the east, SW

Madison Street on the south, and SW

4th Avenue on the west.

Alternatives

The EIS would consider several action

alternatives and a no action alternative.

The facility would be located adjacent

to the new U.S. Courthouse located at

1030 SW 3rd Avenue. Alternatives to be

considered include:

1. Design and construction on a full

block site bounded by SW Taylor Street

on the north, SW 2nd Avenue on the

east, SW Salmon Street on the south,

and SW 3rd Avenue on the west;

2. Design and construction on a full

block site bounded by SW Taylor Street

on the north, SW 3rd Avenue on the

east, SW Salmon Street on the south,

and SW 4th Avenue on the west;

3. Design and construction on a full

block site bounded by SW Main Street

on the north, SW 1st Avenue on the

east, SW Madison Street on the south,

and SW 2nd Avenue on the west;

4. Acquisition then alternation of a

leased building bounded by SW Taylor

Street on the north, SW 1st Avenue on

the east, SW Madison Street on the

south, and SW 4th Avenue on the west,

and,

5. No action.

Probable Effects

GSA will evaluate physical, biological

and socioeconomic environmental

impacts of the alternatives in the EIS.

Potential impacts include, but are not

limited to, changes in physiography;

impacts to groundwater; changes to

vegetation and wildlife; changes in open

space and visual characteristics; impacts

to air quality and noise, utilities, and

transportation; changes in the social

environment; and impacts to zoning and

historical/cultural resources. The

impacts will be evaluated both for the

construction period and during the

operation of the facility. Measures to

mitigate any significant adverse impacts

will be addressed.

Procedures

The EIS will be prepared based on the

outcome of the scoping phase, A Draft

EIS will be made available for public

and agency comments, with a public

hearing held to receive comments

regarding the Draft EIS. Upon

completion of the public review

process, a Final EIS would be prepared

to address issues raised during the Draft

EIS and the public hearing.

Dated: April 26, 1996.

Richard J. Moen,

Legal Counsel, Region 10.

[FR Doc. 96–11542 Filed 5–8–96; 8:45 am]

BILLING CODE 6820–23–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30DAY–10]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review, in compliance with the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Office on (404) 639–7090.

The following requests have been

submitted for review since the last

publication date on January 23, 1996.

Proposed Projects

1. Variability of Respiratory Tract

Dust Deposition in Workers—New—

Adverse respiratory health effects in

workers exposed to hazardous airborne

materials can be prevented by reducing

the concentration of the implicated

agents below a threshold level.

However, the actual ‘‘safe’’ work site

concentration is determined by the

airborne particulates that are actually

deposited and retained in the worker’s

respiratory tract. The proportion

deposited is in turn affected by the

volume and flow rates of the worker’s

breathing patterns.

The goals of this investigation are to:

(1) Develop a database of information

related to workers’ ventilatory patterns

during performance of elemental

industrial and commercial job activities,

as well as specific dust-exposed work

activities; (2) define expected variation

in particle size dependent respiratory

tract dust deposition related to

breathing patterns representative of

different job tasks; (3) investigate

residual intersubject variability in

respiratory tract dust deposition with

explanatory variables such as height,

gender, age smoking status, effective

airway diameter, nasal geometry, and

preexisting respiratory tract

abnormalities.

This investigation should improve the

understanding of the actual deposition

of toxic substances in the lungs and

help to validate or modify the existing

models of human aerosol deposition.

Respondents Number of respondents

Number of responses/respondentAverage burden/response

(in hours)

Phase I:

Screening .............................................................................................................................. 13 1 1

Deposition ............................................................................................................................. 13 1 3

Physio Mon:

Screening .............................................................................................................................. 16 1 2

Work tasks ............................................................................................................................ 16 1 4

Phase II:

Screening .............................................................................................................................. 276 1 2

Work tasks ............................................................................................................................ 276 1 4

Phase III:

Screening .............................................................................................................................. 66 1 1

Physiol ................................................................................................................................... 66 1 2

Deposition ............................................................................................................................. 66 1 1

The total annual burden is 2068. Send

comments to Desk Officer, CDC; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503.

2. Evaluation of the Efficacy of Back

Belts for the Prevention of Low Back

Injury—New—This study will provide

information concerning the efficacy of a

back supporting belt in preventing first

and recurrent low back injuries. The

research will be conducted with a major

retail merchandise company, using

selected company workers (those with

highest lifting exposures) in selected
21186 Federal Register / Vol. 61, No. 91 / Thursday, May 9, 1996 / Notices

stores. NIOSH will obtain much higher

quality information on the value of back

belts in prevention of injuries in the

workplace than is currently available,

and the Institute will be able to make

scientifically justified recommendations

regarding their use of personal

protective equipment to industry and

the public.

Workers will respond to questions

concerning job history, physical

activity, smoking history, history of

injury and back pain, psychosocial

variables in the workplace, tasks

performed on the job. Only data

necessary for the purposes of this study

will be collected, and the questionnaires

will be group administered at the

workplace.

Respondents Number of respondents

Number of responses/respondentAverage burden/responses

(in hours)

Telephone

Interview I .............................................................................................................................. 2700 4 0.42

Interview II ............................................................................................................................. 2700 3 .42

Interview III ............................................................................................................................ 2250 2 .42

Interview IV 350 1 .42

The total burden hours is 9975. Send

comments to Desk Officer, CDC; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503.

Wilma G. Johnson,

Acting Associate Director for Policy Planning

and Evaluation Centers for Disease Control

and Prevention (CDC).

[FR Doc. 96–11597 Filed 5–8–96; 8:45 am]

BILLING CODE 4163–18–P

[INFO–96–16]

Proposed Data Collections Submitted

for Public Comment and

Recommendations

In compliance with the requirement

of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995 for

opportunity for public comment on

proposed data collection projects, the

Centers for Disease Control and

Prevention (CDC) will publish periodic

summaries of proposed projects. To

request more information on the

proposed projects or to obtain a copy of

the data collection plans and

instruments, call the CDC Reports

Clearance Officer on (404) 639–7090.

Comments are invited on: (a) Whether

the proposed collection of information

is necessary for the proper performance

of the functions of the agency, including

whether the information shall have

practical utility; (b) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (c)

ways to enhance the quality, utility, and

clarity of the information to be

collected; and (d) ways to minimize the

burden of the collection of information

on respondents, including through the

use of automated collection techniques

for other forms of information

technology. Send comments to Wilma

Johnson, CDC Reports Clearance Officer,

1600 Clifton Road, MS-D24, Atlanta, GA

30333. Written comments should be

received within 60 days of this notice.

Proposed Projects

1. Importation and Shipment of

Etiologic Agents—(0920–0199)—

Revision—The Antiterrorism and

Effective Death Penalty Act of 1996

(Public Law 104–132) authorizes the

Secretary of Health and Human Services

(HHS) to regulate the transfer of certain

infectious agents harmful to humans.

The Centers for Disease Control and

Prevention (CDC) is the agency within

the Department responsible for

promulgating regulations. CDC is

proposing a rule designed to ensure that

select infectious agents are not shipped

to parties not equipped to handle them

appropriately, or who do not have

legitimate reasons to use them and to

implement a system whereby scientists

and researchers involved in legitimate

research may continue transferring and

receiving these agents without undue

burdens. Respondents include

laboratory facilities such as those

operated by government agencies,

universities, research institutions, and

commercial entities.

Those facilities requesting select

infectious agents listed in the regulation

must register with the Secretary of HHS,

or with registering entities authorized

by the Secretary, as capable and

equipped to handle the select infectious

agents in accordance with guidelines

developed by CDC, the National

Institutes for Health (NIH) and the

Department of Defense.

Once registered, facilities must

complete a federally-developed form,

CDC Form EA–101, for each transfer of

the agent. Information on this form will

include the name of the requestor and

requesting facility, the name of the

transferor and transferring facility, the

name of the responsible facility official

for the transferor and requestor, the

requesting facility’s registration number,

the transferring facility’s registration

number, the name of the agent(s) being

shipped, and the proposed use of the

agent. The package is being revised to

include burden for laboratories to

register with the Secretary. The total

cost to respondents is estimated at

$14,490.

Respondents Number of

respondents

Number of

responses/

respondent

Average

burden/response

(in hours)

Total Burden

(in hrs.)

Laboratory ......................................................................................................................... 100 16 .36 576

Shippers ............................................................................................................................ 20 45 .97 873

Total ........................................................................................................................... .................... .................... .................... 1,449

2. 1997 National Health Interview

Survey, Basic Module—(0920–0214)—

Revision—The annual National Health

Interview Survey (NHIS) is a basic

source of general statistics on the health

of the U.S. population. Due to the

integration of health surveys in the

Department of Health and Human

Services, the NHIS also has become the